Category: Investor updates

Imagion Biosystems gives notice that, on 20 October 2020 the Company issued 2,401,900 fully paid ordinary shares (Shares) in the Company as the result of

Imagion Biosystems announced that it has received a total of $143,157 for the exercise of options. Composed of $142,200 for 2,370,000 options exercisable at 6

Imagion Biosystems today announced “Issue of unlisted performance options under Equity Incentive Plan”. Read the announcement.

The attached “Appendix 3G: Notification of issue, conversion or payment up of equity +securities” was released to market. View Appendix 3G.

Imagion Biosystems has today advised that 2,500,000 performance rights have vested and were issued as ordinary shares to Executive Chairman and CEO, Bob Proulx today,

Imagion Biosystems gives notice that, on 4 September 2020 the Company issued 2,514,666 fully paid ordinary shares (Shares) in the Company as the result of

Imagion Biosystems announce that it has received a total of $82,939.98 for the exercise of Listed Options. Comprised of $64,189.98 for 2,139,666 Listed Options exercisable at

Imagion Biosystems gives notice that, on 27 August 2020 the Company issued 6,080,000 fully paid ordinary shares (Shares) in the Company as the result of